Advanced Enzyme Technologies Ltd has completed the newspaper publication of its Q3FY26 unaudited consolidated financial results, fulfilling regulatory requirements under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company published the extract of financial results in The Financial Express and Mumbai Lakshadeep newspapers on February 01, 2026.

Regulatory Compliance and Publication Details

The company submitted the newspaper publication copies to BSE Limited and National Stock Exchange of India Limited on February 02, 2026, through a formal communication signed by Company Secretary and Head – Legal, Sanjay Basantani. This follows the standard regulatory practice for listed companies to publish their quarterly financial results in newspapers for public disclosure.

Q3FY26 Financial Performance Summary

The published results showcase the company's consolidated financial performance for the quarter and nine months ended December 31, 2025. The newspaper publication included key financial metrics in both English and Marathi languages to ensure broader accessibility for stakeholders.

Nine Months Performance Overview

For the nine months ended December 31, 2025, the company demonstrated strong growth trajectory with total income from operations reaching ₹5,423.90 million compared to ₹4,697.31 million in the corresponding period of previous year, representing a growth of 15.47%.

Standalone Financial Performance

The company also disclosed key standalone financial information, showing total income from operations of ₹955.84 million for Q3FY26 and profit after tax of ₹132.48 million. For the nine months period, standalone operations generated ₹3,363.50 million in revenue with profit after tax of ₹1,095.11 million.

Corporate Communication and Transparency

This newspaper publication represents Advanced Enzyme Technologies' commitment to regulatory compliance and transparent communication with stakeholders. The company maintains its registered office at Sun Magnetica, 'A' wing, 5th Floor, LIC Service Road, Louiswadi, Thane (W)-400 604, and continues to engage with investors through multiple communication channels including its website www.advancedenzymes.com .

Advanced Enzyme Technologies Limited has notified stock exchanges regarding the structural conversion of its statutory auditing firm from M S K A & Associates to M S K A & Associates LLP, effective January 13, 2026. The company received formal intimation from the auditors on January 14, 2026, and subsequently informed BSE and NSE on January 15, 2026.

Auditor Firm Conversion Details

The statutory auditing firm M S K A & Associates, Chartered Accountants, has converted itself into a Limited Liability Partnership under the provisions of the Limited Liability Partnership Act, 2008. The firm is now operating as M S K A & Associates LLP, Chartered Accountants with a new ICAI Firm Registration Number 105047W/W101187.

Continuity of Audit Services

The conversion to LLP structure does not impact the ongoing audit engagement with Advanced Enzyme Technologies. The newly formed M S K A & Associates LLP will continue to function and discharge its duties as the statutory auditors of the company for the remaining period of their appointed term. This ensures seamless continuation of auditing services without any disruption to the company's statutory compliance requirements.

Regulatory Communication

Advanced Enzyme Technologies' Company Secretary and Head of Legal, Sanjay Basantani, communicated this development to both major stock exchanges where the company's shares are listed. The notification was sent to BSE Limited (Scrip Code: 540025) and National Stock Exchange of India Limited (Trading Symbol: ADVENZYMES) as part of regulatory disclosure requirements under applicable listing regulations.

The company emphasized that this structural change in the auditing firm is purely administrative and maintains the same professional relationship and audit standards that were previously established with M S K A & Associates.